T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFM
751
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $64.5M | 0.01% |
1,564,644
+9,937
| +0.6% | +$378K |
|
752
Compass Minerals
CMP
$1.12B
| $64.3M | 0.01% |
740,238
-164,368
| -18% | -$14.1M |
|
753
Teradyne
TER
$63B
| $64.2M | 0.01% |
3,246,079
+10,665
| +0.3% | +$201K |
|
754
Chubb
CB
$132B
| $63.9M | 0.01% |
556,380
+10,120
| +2% | +$1.12M |
|
755
Commault Systems
CVLT
$5.87B
| $63.9M | 0.01% |
1,235,548
-236,002
| -16% | -$11.3M |
|
|
NEWR
756
DELISTED
New Relic, Inc.
NEWR
| $63.7M | 0.01% |
+1,904,656
| New | +$62.3M |
|
757
UFP Industries
UFPI
$5.06B
| $63.7M | 0.01% |
3,590,490
-749,760
| -17% | -$12.2M |
|
|
WPP
758
DELISTED
WAUSAU PAPER CORP.
WPP
| $63.4M | 0.01% |
5,576,190
+1,295,620
| +30% | +$12.8M |
|
759
Hexcel
HXL
$7.74B
| $63.3M | 0.01% |
1,526,806
+4,736
| +0.3% | +$195K |
|
|
RCPT
760
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $63.1M | 0.01% |
+515,173
| New | +$52.2M |
|
|
SMRT
761
DELISTED
Stein Mart Inc
SMRT
| $62.7M | 0.01% |
4,286,080
-36,930
| -0.9% | -$498K |
|
762
Adobe
ADBE
$103B
| $62.3M | 0.01% |
856,806
+19,520
| +2% | +$1.37M |
|
|
RNET
763
DELISTED
RigNet, Inc.
RNET
| $62.1M | 0.01% |
1,514,300
+325,700
| +27% | +$13.4M |
|
764
Dorman Products
DORM
$3.97B
| $62.1M | 0.01% |
1,286,920
-1,033,780
| -45% | -$47.9M |
|
765
IPG Photonics
IPGP
$3.71B
| $62M | 0.01% |
828,157
-80,573
| -9% | -$5.73M |
|
766
Banco Santander Chile
BSAC
$16B
| $62M | 0.01% |
3,144,901
+34,768
| +1% | +$741K |
|
767
Travelers Companies
TRV
$77.2B
| $62M | 0.01% |
585,507
+9,740
| +2% | +$983K |
|
768
Silicon Laboratories
SLAB
$7.3B
| $61.9M | 0.01% |
1,299,360
+194,040
| +18% | +$8.56M |
|
|
KNL
769
DELISTED
Knoll, Inc.
KNL
| $61.8M | 0.01% |
2,921,550
+88,330
| +3% | +$1.69M |
|
|
TRCO
770
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $61.7M | 0.01% |
+1,033,100
| New | +$63.4M |
|
771
Royal Caribbean
RCL
$82.4B
| $61.7M | 0.01% |
748,778
+602,319
| +411% | +$42.3M |
|
|
CVT
772
DELISTED
CVENT, INC.
CVT
| $61.7M | 0.01% |
2,215,536
-396,849
| -15% | -$10.4M |
|
|
TUMI
773
DELISTED
TUMI HLDGS INC COM
TUMI
| $61.5M | 0.01% |
2,591,158
-2,801,562
| -52% | -$59.3M |
|
|
ISEE
774
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $61.5M | 0.01% |
1,370,042
+1,668
| +0.1% | +$70.1K |
|
|
ALEX
775
DELISTED
Alexander & Baldwin
ALEX
| $61.2M | 0.01% |
1,559,382
+156,909
| +11% | +$5.96M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.